Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
1.060
-0.010 (-0.93%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Lisata Therapeutics Employees
Lisata Therapeutics had 21 employees as of December 31, 2025. The number of employees decreased by 5 or -19.23% compared to the previous year.
Employees
21
Change (1Y)
-5
Growth (1Y)
-19.23%
Revenue / Employee
$4,762
Profits / Employee
-$696,238
Market Cap
9.65M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 21 | -5 | -19.23% |
| Dec 31, 2024 | 26 | 1 | 4.00% |
| Dec 31, 2023 | 25 | -2 | -7.41% |
| Dec 31, 2022 | 27 | 0 | - |
| Dec 31, 2021 | 27 | 3 | 12.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Senti Biosciences Holdings | 39 |
| Lunai Bioworks | 29 |
| IN8bio | 18 |
| Theriva Biologics | 16 |
| CalciMedica | 16 |
| Lexaria Bioscience | 7 |
| Quoin Pharmaceuticals | 6 |
LSTA News
- 3 days ago - Lisata Therapeutics Quarterly report: Q2 2026 - Filings
- 5 days ago - Lisata Therapeutics provides update following termination of Kuva Labs merger - TheFly
- 6 days ago - Lisata Therapeutics Provides Update Following Termination of Merger Agreement - GlobeNewsWire
- 13 days ago - Lisata Therapeutics terminates merger with Kuva Labs - TheFly
- 13 days ago - Lisata Therapeutics downgraded to Hold from Buy at Brookline - TheFly
- 6 weeks ago - Johnson Fistel Investigates Lisata Therapeutics, Inc. (LSTA) After Disclosures Concerning Acquisition Financing - GlobeNewsWire
- 7 weeks ago - SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Lisata Therapeutics, Inc. (LSTA) - Newsfile Corp
- 2 months ago - Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc. - GlobeNewsWire